SCHEMBL2813429

SCHEMBL2813429

c1ccc(N2CCc3n[nH]c4nc(N5CCCC5)nc2c34)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
HTT P42858 2/20 0.41
PIK3CA P42336 3/20 0.41
GAA P10253 6/20 0.40
HPGD P15428 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
GLA P06280 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 1/20 0.39
KDM4E B2RXH2 4/20 0.38
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 2/20 0.37
TAAR1 Q96RJ0 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPY5R Q15761 1/20 0.36
ALOX15 P16050 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14405861 0.93 MAPT (0.48) ALDH1A1HTTPIK3CAGAAHPGD
SCHEMBL2812138 0.91 PIK3CA (0.52) ALDH1A1HTTPIK3CAGAAHPGD
SCHEMBL2808533 0.88 PIK3CA (0.45) ALDH1A1PIK3CAGAAHPGDHSD17B10
SCHEMBL2811694 0.87 GAA (0.50) ALDH1A1HTTPIK3CAGAAHPGD
SCHEMBL2812038 0.79 BRS3 (0.44) GAAHPGDL3MBTL1GLAHSD17B10
SCHEMBL538300 0.78 KDM4E (0.43) ALDH1A1GAAHPGDL3MBTL1GLA
SCHEMBL538612 0.77 HTT (0.41) ALDH1A1HTTGAAHPGDTSHR
SCHEMBL13131430 0.77 CASP1 (0.44) ALDH1A1HTTGAAHPGDL3MBTL1
SCHEMBL2812360 0.76 DRD4 (0.43) ALDH1A1HTTGAAHPGDL3MBTL1
SCHEMBL537678 0.74 HRH4 (0.42) ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 ALDH1A1 924/4885HTT 2797/4885PIK3CA 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.